Loading...

Cost Optimization And Industrial Demand Will Shape Future Markets

Published
11 Sep 24
Updated
05 Dec 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-73.1%
7D
14.9%

Author's Valuation

US$6.8346.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 05 Dec 25

ASPN: Improving Risk Profile Will Support Long-Term Opportunity Despite Wider Losses

Analysts have raised their price target on Aspen Aerogels by a modest amount, now embedding slightly lower discount rates and marginally softer future valuation multiples, as they emphasize the company’s improving risk profile and steady long term growth outlook.

What's in the News

  • Aspen Aerogels lowered its full year 2025 revenue guidance to a range of $270 million to $280 million, down from the prior outlook of $297 million to $317 million (company guidance).
  • The company now expects a wider net loss for 2025, guiding to a range of $342 million to $334 million compared with previous expectations of $317 million to $307 million, with basic loss per share projected at $4.15 to $4.05 versus $3.86 to $3.73 previously (company guidance).
  • For the fourth quarter of 2025, Aspen Aerogels issued revenue guidance of $40 million to $50 million, framing near term expectations amid the revised annual outlook (company guidance).
  • Management slightly revised its impairment guidance on property, plant and equipment for 2025, now expecting $287.6 million of impairments compared with the prior estimate of $287.567 million (company guidance).

Valuation Changes

  • Discount Rate decreased modestly from 8.51% to approximately 8.36%, reflecting a slightly lower perceived risk profile in the valuation model.
  • Revenue Growth remained essentially unchanged at roughly 5.12%, indicating no meaningful revision to long term top line expansion assumptions.
  • Net Profit Margin was effectively flat at about 8.18%, suggesting stable expectations for long run profitability.
  • Future P/E edged down slightly from about 21.89x to 21.80x, implying marginally softer valuation multiples applied to projected earnings.
  • Fair Value was unchanged at 6.83, indicating no net effect on the intrinsic value estimate despite parameter tweaks.

Key Takeaways

  • Cost reductions and process improvements are enhancing profitability and positioning the company for stronger earnings even at modest revenue levels.
  • Strategic focus on EV thermal barriers and U.S.-based manufacturing aligns with regulatory trends, supporting future growth and market share expansion.
  • Heavy reliance on key segments and customers, regulatory uncertainty, and ongoing margin pressures threaten growth projections and create revenue and earnings vulnerability.

Catalysts

About Aspen Aerogels
    An aerogel technology company, designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industrial, sustainable insulation materials, and electric vehicle (EV) markets in the United States, Canada, Asia, Europe, and Latin America.
What are the underlying business or industry changes driving this perspective?
  • Aspen's cost optimization-reducing fixed costs by ~$65M and streamlining operations-substantially lowers the revenue threshold needed to achieve profitability. This greater operating leverage, combined with a stable cost structure and controlled CapEx, is set to significantly improve EBITDA and net margin even at modest revenue recovery.
  • Medium-term visibility into a rebound in project-based Energy Industrial revenues (subsea/LNG), as key customers' 2025 wins and robust project backlogs are expected to drive attractive incremental revenue and high gross margins from 2026 onwards.
  • Strong positioning in the EV thermal barrier market with major OEMs like GM, Stellantis, and Daimler, alongside active new quoting and prototyping activities, underpins a path toward multi-year revenue acceleration as electrification in transportation and strict emissions regulations continue to ramp up globally.
  • Ongoing process improvements and increased production efficiency at the Rhode Island and Mexico facilities are driving productivity gains and gross margin expansion, further boosting long-term earnings power and resilience to lower EV production volatility.
  • Domestic manufacturing capacity and flexible sourcing strategies cater to automaker preferences for U.S.-based supply and position Aspen as a preferred supplier amid intensifying regulations favoring energy efficiency and sustainability, supporting long-term revenue growth and market share gains.

Aspen Aerogels Earnings and Revenue Growth

Aspen Aerogels Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Aspen Aerogels's revenue will grow by 8.9% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -78.5% today to 12.3% in 3 years time.
  • Analysts expect earnings to reach $62.9 million (and earnings per share of $0.72) by about September 2028, up from $-311.9 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $32.2 million.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 15.9x on those 2028 earnings, up from -1.8x today. This future PE is lower than the current PE for the US Chemicals industry at 25.9x.
  • Analysts expect the number of shares outstanding to grow by 0.38% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.91%, as per the Simply Wall St company report.

Aspen Aerogels Future Earnings Per Share Growth

Aspen Aerogels Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Slower-than-expected demand recovery in the Energy Industrial segment, with continued destocking by distributors and delayed project activity (especially in subsea and LNG markets), exposes Aspen to prolonged revenue weakness and challenges the assumption of strong growth in this core business.
  • High customer concentration in the EV Thermal Barrier segment, particularly reliance on GM, poses a risk to future revenues and earnings if GM's EV production or market share stalls or declines, as suggested by management noting production levels tracking IHS forecasts and emphasizing GM's outsized impact.
  • Ongoing policy and regulatory volatility in key markets (notably the U.S. EV market) create uncertainty for EV adoption rates and timing of OEM launches, potentially undermining anticipated topline growth and slowing earnings improvement.
  • Adjacent OEM programs, design-in activity, and new platform launches outside of current key customers (e.g., Daimler, Stellantis, ACC) have uncertain timelines or significant slippage due to shifting automaker plans and reaction to changing government incentives, posing risk to the realization of outsized growth projections for 2026-2027.
  • The need for persistent R&D and capital expenditures to remain competitive combined with achieved cost reductions cycling out of the base may limit further margin expansion, while risks such as commodity price volatility and potential industry-wide pricing pressure could negatively impact future gross margins and net income.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $9.583 for Aspen Aerogels based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $14.0, and the most bearish reporting a price target of just $6.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $513.3 million, earnings will come to $62.9 million, and it would be trading on a PE ratio of 15.9x, assuming you use a discount rate of 7.9%.
  • Given the current share price of $6.66, the analyst price target of $9.58 is 30.5% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives